-
Signature
-
/s/ Nathaniel Adams, Attorney-in-fact
-
Issuer symbol
-
XENE
-
Transactions as of
-
28 Nov 2025
-
Net transactions value
-
-$4,366
-
Form type
-
4
-
Filing time
-
03 Dec 2025, 20:20:44 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| MORTIMER IAN |
PRESIDENT & CEO, Director |
3650 GILMORE WAY, BURNABY, BRITISH COLUMBIA, CANADA |
/s/ Nathaniel Adams, Attorney-in-fact |
03 Dec 2025 |
0001619961 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
XENE |
Common Shares |
Sale |
$4,366 |
-97 |
-0.31% |
$45.01 |
31,205 |
28 Nov 2025 |
Direct |
F1 |
| holding |
XENE |
Common Shares |
|
|
|
|
|
14,300 |
28 Nov 2025 |
By Spouse |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: